SEARCH
Alzheimer's drug slowed progression of disease in late-stage study, drugmakers say - 1breakingnews.c
1BN-General
2022-09-28
Views
11
Description
Share / Embed
Download This Video
Report
Officials said they will submit the new trial results to the FDA to bolster its case that lecanemab should be approved as an Alzheimer's treatment.
VIEW MORE : https://bit.ly/1breakingnews
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x8e17su" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:44
Alzheimer's drug slowed progression of disease in late-stage study, drugmakers say - 1breakingnews.c
05:55
API Makers Don't Share Drugmakers' Pain
01:51
Drugmakers push back on vaccine patent waiver
00:46
Drugmakers Under Investigation For Possible Price Fixing of Diabetic Drugs
01:16
Drugmakers ask EU to loosen rules for COVID-19 vaccine
12:14
#LagingHanda | Kongreso, hinimok ang mga concerned gov't agencies na bilisan ang pagbibigay ng mga kinakailangang permits sa local drugmakers
00:53
The FDA Accuses Major Drugmakers Of 'Gaming' The System
01:16
Donald Trump Tells Drugmakers to Manufacture in the US
04:10
Court strikes down Trump rule that drugmakers disclose price
05:06
Breaking down the fight between drugmakers White House over price slashing
05:40
A Revival Of Drugmakers
05:43
Why Indian Drugmakers Are In More Pain
